-
Facility is a center of excellence for the design of innovative solutions that will bring further revolutionary developments for radiology, pathology and healthcare delivery as a whole to image-enable the...
» Read more
-
Children in the United States and Great Britain share a number of common risk factors that increase the likelihood that they will have behavioral problems-and Britain's broader social welfare programs don...
» Read more
-
Restoring the front teeth after a traumatic injury poses a particular challenge—biologically, functionally, and aesthetically. Even when all the procedures of a successful implant are followed, healing...
» Read more
-
Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a dis tinct...
» Read more
-
In just days, a number of generic versions of Lipitor will hit pharmacy shelves. Pfizer's 180-day generic exclusivity agreement for the medication expires at the end of the month. That will bring a ho st...
» Read more
-
A well-known genetic risk factor for Alzheimer's disease triggers a cascade of signaling that ultimately results in leaky blood vessels in the brain, allowing toxic substances to pour into brain tissu e...
» Read more
-
Health and Human Services (HHS) Secretary Kathleen Sebelius announced today that Illinois, Nevada, Oregon, South Dakota, Tennessee and Washington will receive more than $181 million in grants to help implement...
» Read more
-
For older adults with "C2" fractures of the upper (cervical) spine, surgery and nonsurgical treatment provide similar short- and long-term outcomes, reports a study in the May issue of Neurosurgery, o fficial...
» Read more
-
Why diabetics suffer from increased pain and temperature sensitivity is a step closer to being understood and effectively treated.
» Read more
-
Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid-, following a stem cell transplant, according to a study co-authored by a...
» Read more